189 related articles for article (PubMed ID: 21640380)
1. Identification of a novel, tissue-specific ABCG2 promoter expressed in pediatric acute megakaryoblastic leukemia.
Campbell PK; Zong Y; Yang S; Zhou S; Rubnitz JE; Sorrentino BP
Leuk Res; 2011 Oct; 35(10):1321-9. PubMed ID: 21640380
[TBL] [Abstract][Full Text] [Related]
2. Expression of mouse Abcg2 mRNA during hematopoiesis is regulated by alternative use of multiple leader exons and promoters.
Zong Y; Zhou S; Fatima S; Sorrentino BP
J Biol Chem; 2006 Oct; 281(40):29625-32. PubMed ID: 16885162
[TBL] [Abstract][Full Text] [Related]
3. Low levels of ABCG2 expression in adult AML blast samples.
Abbott BL; Colapietro AM; Barnes Y; Marini F; Andreeff M; Sorrentino BP
Blood; 2002 Dec; 100(13):4594-601. PubMed ID: 12393637
[TBL] [Abstract][Full Text] [Related]
4. Bcrp1 transcription in mouse testis is controlled by a promoter upstream of a novel first exon (E1U) regulated by steroidogenic factor-1.
Xie Y; Natarajan K; Bauer KS; Nakanishi T; Beck WT; Moreci RS; Jeyasuria P; Hussain A; Ross DD
Biochim Biophys Acta; 2013 Dec; 1829(12):1288-99. PubMed ID: 24189494
[TBL] [Abstract][Full Text] [Related]
5. Blast cell deficiency of CD11a as a marker of acute megakaryoblastic leukemia and transient myeloproliferative disease in children with and without Down syndrome.
Boztug H; Schumich A; Pötschger U; Mühlegger N; Kolenova A; Reinhardt K; Dworzak M
Cytometry B Clin Cytom; 2013; 84(6):370-8. PubMed ID: 23450818
[TBL] [Abstract][Full Text] [Related]
6. Chemotherapeutic drug-induced ABCG2 promoter demethylation as a novel mechanism of acquired multidrug resistance.
Bram EE; Stark M; Raz S; Assaraf YG
Neoplasia; 2009 Dec; 11(12):1359-70. PubMed ID: 20019844
[TBL] [Abstract][Full Text] [Related]
7. Functional characterization of the ABCG2 5' non-coding exon variants: Stem cell specificity, translation efficiency and the influence of drug selection.
Sándor S; Jordanidisz T; Schamberger A; Várady G; Erdei Z; Apáti Á; Sarkadi B; Orbán TI
Biochim Biophys Acta; 2016 Jul; 1859(7):943-51. PubMed ID: 27191194
[TBL] [Abstract][Full Text] [Related]
8. The C421A (Q141K) polymorphism enhances the 3'-untranslated region (3'-UTR)-dependent regulation of ATP-binding cassette transporter ABCG2.
Ripperger A; Benndorf RA
Biochem Pharmacol; 2016 Mar; 104():139-47. PubMed ID: 26903388
[TBL] [Abstract][Full Text] [Related]
9. Regulation of ABCG2 expression at the 3' untranslated region of its mRNA through modulation of transcript stability and protein translation by a putative microRNA in the S1 colon cancer cell line.
To KK; Zhan Z; Litman T; Bates SE
Mol Cell Biol; 2008 Sep; 28(17):5147-61. PubMed ID: 18573883
[TBL] [Abstract][Full Text] [Related]
10. Expression of ABCG2 (BCRP) is regulated by Nrf2 in cancer cells that confers side population and chemoresistance phenotype.
Singh A; Wu H; Zhang P; Happel C; Ma J; Biswal S
Mol Cancer Ther; 2010 Aug; 9(8):2365-76. PubMed ID: 20682644
[TBL] [Abstract][Full Text] [Related]
11. Novel 5' untranslated region variants of BCRP mRNA are differentially expressed in drug-selected cancer cells and in normal human tissues: implications for drug resistance, tissue-specific expression, and alternative promoter usage.
Nakanishi T; Bailey-Dell KJ; Hassel BA; Shiozawa K; Sullivan DM; Turner J; Ross DD
Cancer Res; 2006 May; 66(10):5007-11. PubMed ID: 16707421
[TBL] [Abstract][Full Text] [Related]
12. ABCG2 expression, function, and promoter methylation in human multiple myeloma.
Turner JG; Gump JL; Zhang C; Cook JM; Marchion D; Hazlehurst L; Munster P; Schell MJ; Dalton WS; Sullivan DM
Blood; 2006 Dec; 108(12):3881-9. PubMed ID: 16917002
[TBL] [Abstract][Full Text] [Related]
13. The t(1;22) (p13;q13) is nonrandom and restricted to infants with acute megakaryoblastic leukemia: a Pediatric Oncology Group Study.
Carroll A; Civin C; Schneider N; Dahl G; Pappo A; Bowman P; Emami A; Gross S; Alvarado C; Phillips C
Blood; 1991 Aug; 78(3):748-52. PubMed ID: 1859887
[TBL] [Abstract][Full Text] [Related]
14. Coexpression of erythroid and megakaryocytic genes in acute erythroblastic (FAB M6) and megakaryoblastic (FAB M7) leukaemias.
Linari S; Vannucchi AM; Ciolli S; Leoni F; Caporale R; Grossi A; Pagliai G; Santini V; Paoletti F; Ferrini PR
Br J Haematol; 1998 Sep; 102(5):1335-7. PubMed ID: 9753066
[TBL] [Abstract][Full Text] [Related]
15. Increased levels of a chromosome 21-encoded tumour invasion and metastasis factor (TIAM1) mRNA in bone marrow of Down syndrome children during the acute phase of AML(M7).
Ives JH; Dagna-Bricarelli F; Basso G; Antonarakis SE; Jee R; Cotter F; Nizetić D
Genes Chromosomes Cancer; 1998 Sep; 23(1):61-6. PubMed ID: 9713998
[TBL] [Abstract][Full Text] [Related]
16. Lapatinib (Tykerb, GW572016) reverses multidrug resistance in cancer cells by inhibiting the activity of ATP-binding cassette subfamily B member 1 and G member 2.
Dai CL; Tiwari AK; Wu CP; Su XD; Wang SR; Liu DG; Ashby CR; Huang Y; Robey RW; Liang YJ; Chen LM; Shi CJ; Ambudkar SV; Chen ZS; Fu LW
Cancer Res; 2008 Oct; 68(19):7905-14. PubMed ID: 18829547
[TBL] [Abstract][Full Text] [Related]
17. Regulations of ABCB1 and ABCG2 expression through MAPK pathways in acute lymphoblastic leukemia cell lines.
Tomiyasu H; Watanabe M; Sugita K; Goto-Koshino Y; Fujino Y; Ohno K; Sugano S; Tsujimoto H
Anticancer Res; 2013 Dec; 33(12):5317-23. PubMed ID: 24324065
[TBL] [Abstract][Full Text] [Related]
18. High-dose methotrexate in Egyptian pediatric acute lymphoblastic leukemia: the impact of ABCG2 C421A genetic polymorphism on plasma levels, what is next?
El Mesallamy HO; Rashed WM; Hamdy NM; Hamdy N
J Cancer Res Clin Oncol; 2014 Aug; 140(8):1359-65. PubMed ID: 24718721
[TBL] [Abstract][Full Text] [Related]
19. Comparison of childhood myelodysplastic syndrome, AML FAB M6 or M7, CCG 2891: report from the Children's Oncology Group.
Barnard DR; Alonzo TA; Gerbing RB; Lange B; Woods WG;
Pediatr Blood Cancer; 2007 Jul; 49(1):17-22. PubMed ID: 16856158
[TBL] [Abstract][Full Text] [Related]
20. FLT3-ITD and MLL-PTD influence the expression of MDR-1, MRP-1, and BCRP mRNA but not LRP mRNA assessed with RQ-PCR method in adult acute myeloid leukemia.
Nasilowska-Adamska B; Solarska I; Paluszewska M; Malinowska I; Jedrzejczak WW; Warzocha K
Ann Hematol; 2014 Apr; 93(4):577-93. PubMed ID: 24030729
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
